PennyTrader.com, announced today that it has initiated Profile Coverage of Neuro-Biotech Corp. (PINKSHEET: MRES) on its exclusive penny stock alert service. Neuro-Biotech is a worldwide based biotechnological enterprise involved in clinical neuroscience diagnostic testing related to stress management and mental health for prevention, early diagnosis and therapeutic follow-up. Neuro-Biotech recently announced having reached debt free status.
About Neuro-Biotech Corp. (PINKSHEET: MRES)
As a result of years of study, Neuro-Biotech Corp. has discovered how, following a stressful event, the body’s three systems (Endocrine, Nervous and Immune) work together to protect the body through the HPAS Axis.
The foundation of all Neuro-Biotech Corp. activities is based on this unique communication pathway.
Neuro-Biotech’s vision is to be the first neuro-pharmaceutical company to bring to market analytical diagnostic products specifically designed to facilitate early diagnosis and monitoring. This will allow follow-up treatments via a targeted therapeutic approach to the major psycho-social environmental diseases related to the neuro-psycho-endocrine and immune systems.
Earlier this year, the Company signed 16 worldwide license agreements exclusively for the manufacturing and distribution of two groups of products.
The first is an innovative portfolio of quantitative “in vitro” diagnostic kits, the NeuroBio Tests. These offer easy detection of various molecules released within the blood of subjects suffering from stress and neuroscience — related disorders.
They can be stress-related, socio-professional and occupational diseases, such as Chronic Fatigue Syndrome (CFS), Great Anxiety (GA), Panic Syndrome (PS); Cardiovascular diseases like Essential Hypertension or Arrhythmia; Neurodegenerative diseases such as Alzheimer or Parkinson’s Disease as well as Mental-Health Disorders in the vein of Depression and Schizophrenia.
Using Neuro-Biotech Corporation’s diagnostic kits for early detection, physicians will be able to tell their patients how the chronic stress affects their health, to prescribe the appropriated treatments and to prevent the stress-related diseases and avoid absenteeism.
The second group of products is natural brain adaptogene products — called Neuroceuticals™. These are specifically designed to stimulate targeted neurotransmitters and provide health benefit effects. These are ready to be introduced to the market.
Neuro-Biotech Corp.’s goals are to develop and commercialize quantitative diagnostic blood tests for early diagnosis, monitoring and follow-up for a large range of neuroscience and stress related disorders. This is to accommodate unsatisfied medical needs and develop their own extensive portfolio of diagnostic tests and natural brain neuroceuticals.
Neuro-Biotech Corporation is now able to become worldwide leader in the field of clinical applied-neuroscience related to stress management and mental health for prevention, early diagnosis and therapeutic follow-up.
For full a detailed quote and news visit: CLICK HERE
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: Pennytrader.com has not been compensated for current coverage of MRES advertising and promotional services.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer Click Here
